These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10856473

  • 1. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
    Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L.
    Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
    [Abstract] [Full Text] [Related]

  • 2. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 3. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 4. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr 15; 113(2):209-13. PubMed ID: 15063962
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 15; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperandrogenism and hyperinsulinemia in PCOS patients with essential amino acids. A pilot clinical study].
    Unfer V, Zacchè M, Serafini A, Redaelli A, Papaleo E.
    Minerva Ginecol; 2008 Oct 15; 60(5):363-8. PubMed ID: 18854802
    [Abstract] [Full Text] [Related]

  • 7. Metformin therapy in women with polycystic ovary syndrome.
    Aruna J, Mittal S, Kumar S, Misra R, Dadhwal V, Vimala N.
    Int J Gynaecol Obstet; 2004 Dec 15; 87(3):237-41. PubMed ID: 15548396
    [Abstract] [Full Text] [Related]

  • 8. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 9. The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.
    Dravecká I, Figurová J, Javorský M, Petríková J, Vaľková M, Lazúrová I.
    Physiol Res; 2016 Nov 23; 65(5):815-822. PubMed ID: 27429113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula "tiangui fang"].
    Hou J, Yu J, Wei M.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Aug 23; 20(8):589-92. PubMed ID: 11789189
    [Abstract] [Full Text] [Related]

  • 12. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.
    Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ.
    Metabolism; 1994 May 23; 43(5):647-54. PubMed ID: 8177055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
    Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K.
    Gynecol Endocrinol; 2004 Sep 23; 19(3):125-33. PubMed ID: 15697073
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ.
    Fertil Steril; 2010 Jan 23; 93(1):184-91. PubMed ID: 19019358
    [Abstract] [Full Text] [Related]

  • 17. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD, Silva Lara LA, Japur de Sá Rosa-e-Silva AC, Ferriani RA, Reis RM.
    Gynecol Endocrinol; 2013 Mar 23; 29(3):246-9. PubMed ID: 23194004
    [Abstract] [Full Text] [Related]

  • 18. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.
    Gynecol Endocrinol; 2007 Mar 23; 23(3):146-52. PubMed ID: 17454168
    [Abstract] [Full Text] [Related]

  • 19. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May 23; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A.
    Eur J Endocrinol; 1998 Mar 23; 138(3):269-74. PubMed ID: 9539300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.